HAYWARD, Calif., Jan. 8 /PRNewswire-FirstCall/ -- Solta Medical, Inc. (Nasdaq: SLTM), a global leader in the medical aesthetics market, today announced that it will present at the 12th Annual Needham Growth Stock Conference at the New York Palace Hotel. The Company's presentation is scheduled for 9:20 a.m. Eastern Time on January 14, 2010. Stephen J. Fanning, Chairman, President and Chief Executive Officer, will review the company's business strategy and recent corporate events.
Solta will offer a live audio webcast of its presentation which may be accessed at the Investor Relations section of the Company's website at www.solta.com. An archived replay of the presentation will be available for 30 days, also at www.solta.com.
About Solta Medical, Inc.
Solta Medical, Inc. is a global leader in the medical aesthetics market providing innovative, safe, and effective anti-aging solutions for patients that enhance and expand the practice of medical aesthetics for physicians.
The company offers products to address aging skin under the industry's two premier brands: Thermage® and Fraxel®. Thermage is an innovative, non-invasive radiofrequency procedure for tightening and contouring skin. As the leader in fractional laser technology, Fraxel delivers minimally invasive clinical solutions to resurface aging and sun damaged skin. Since 2002, over one million Thermage and Fraxel procedures have been performed in nearly 80 countries. Thermage and Fraxel are the perfect complement for any aesthetic practice. For more information about Solta Medical, call 1-877-782-2286 or log on to www.Solta.com.
SOURCE Solta Medical, Inc.